DIA: Driving Insights to Action

Growing Irrelevancy of Pre- versus Post-Market Divide for EU Medical Devices

Nanotechnology, mobile medical apps, 3-D printing, and other innovations in medical devices, companion diagnostics, and combination products, plus new Medical Device and In Vitro Diagnostic Device Regulations, are all part of the changing scientific, legislative, and regulatory landscape for Medical Devices in the EU. John Wilkinson, Director of Devices for the Medicines and Healthcare Products Regulatory Agency (MHRA), UK, and co-lead for DIA’s 28th EuroMeeting Medical Devices Theme, discusses these and related topics with DIA Global Forum Deputy Editor Dr. Alberto Grignolo.

Crossroads in Europe: Access from a Market and HTA Perspective

The Health Technology Assessments (HTA) Theme of DIA’s 28th Annual EuroMeeting overviewed topics at the crossroads of regulatory, traditional HTA, and payer discussions. In this podcast, Edith Frénoy, Director for Market Access and HTA for the European Federation of Pharmaceutical Industries & Associations (EFPIA), Belgium, discusses current policies and upcoming issues with DIA Global Forum Deputy Editor Dr. Alberto Grignolo.

A Visionary Takes the Helm at DIA Europe, Middle East & Africa (DIA EMEA)

In February 2016, Dr. Holger Adelmann was appointed Senior Vice President and Managing Director for DIA Europe, Middle East and Africa (DIA EMEA). Dr. Adelmann previously served as the Global Head of Merck Serono’s Clinical Pharmacology and Clinical Biomarker operations, where he re-engineered the Clinical Biomarker and Companion Diagnostics business to better align with the company’s upcoming portfolio. In this podcast from DIA’s flagship offering in Europe, our 28th Annual EuroMeeting, Holger and DIA Global Forum Deputy Editor Dr. Alberto Grignolo discuss the progress and promise of DIA EMEA.

Steps to Meet the “Big Quality” Challenge of “Big Data”

The increasing volume of data collected and the corresponding analytical and logistical challenges around it are hot topics throughout the global clinical research enterprise, including our recent 28th Annual EuroMeeting. In this podcast, Detlef Nehrdich, Senior Associate for Waife and Associates in Germany, and co-lead of the EuroMeeting Theme on eHealth and Big Data, discusses the current and potential value of big data and eHealth with DIA Global Forum Deputy Editor Dr. Alberto Grignolo. 

Innovation: Can it Span the “Efficacy versus Effectiveness Gap”?

Innovation is not enough: Translating life science innovations into tangible patient benefits requires corresponding innovation in the tools and methodologies that inform regulatory, reimbursement and clinical decisions about patient access and treatment. In this podcast, Dr. Hans-George Eichler, Senior Medical Officer for the European Medicines Agency, discusses innovation and related topics with DIA Global Forum Deputy Editor Dr. Alberto Grignolo.

Dr. Kemal Malik Ponders “Is Innovation Always the Answer?”

In a world in which new therapies are being developed at a phenomenal rate, is innovation always the answer? Organized around the theme INnovation: Do You Win by Being IN?, our 28th Annual DIA EuroMeeting explored when, where, and how, innovation leads to advances in health care product development. In this podcast, DIA Global Forum Deputy Editor Dr. Alberto Grignolo interviews EuroMeeting Co-Chair Dr. Kemal Malik, who serves on the Board of Management for Bayer, Germany, about innovation and related topics.

EMA Senior Medical Officer Explains “Access versus Evidence Tradeoff”

As Senior Medical Officer of the European Medicines Agency, Dr. Hans-Georg Eichler has advised the EMA Executive Director on scientific and public health issues since 2007. Dr. Eichler concurrently serves on several medical advisory boards at the Austrian Ministry of Health, and will serve as Co-Chair for our DIA 2016 Annual Meeting in June 2016, in Philadelphia. In this conversation with DIA Global Forum Deputy Director Dr. Alberto Grignolo, Dr. Eichler shares his hopes for the utility of big data and real world data, and other critical issues in drug development and regulatory science.

DIA 2016 Co-Chair: "A Market for Ideas" in a Global Forum

Dr. Hans-Georg Eichler, Senior Medical Officer for the European Medicines Agency and meeting co-chair, discusses his "gold nugget" expectations for our DIA 2016 Annual Meeting in this compelling interview conducted by Dr. Alberto Grignolo, Deputy Editor for the DIA Global Forum.